Edition:
United States

Orion Oyj (ORNAV.HE)

ORNAV.HE on Helsinki Stock Exchange

29.50EUR
16 Feb 2018
Change (% chg)

€0.25 (+0.85%)
Prev Close
€29.25
Open
€29.60
Day's High
€30.25
Day's Low
€29.35
Volume
31,918
Avg. Vol
10,183
52-wk High
€58.35
52-wk Low
€28.00

Latest Key Developments (Source: Significant Developments)

Orion Q4 EBIT Above Expectations At EUR 73.1‍​ Million
Wednesday, 7 Feb 2018 05:45am EST 

Feb 7 (Reuters) - ORION OYJ ::‍ESTIMATES THAT IN 2018 NET SALES WILL BE AT SAME LEVEL OR SLIGHTLY LOWER THAN IN 2017​.SEES 2018 OPERATING PROFIT EXCLUDING MATERIAL CAPITAL GAINS WILL BE LOWER THAN IN 2017​.Q4 SALES EUR 280.4 MILLION (REUTERS POLL EUR 283 MILLION).‍PROPOSES PAYMENT OF A DIVIDEND OF EUR 1.45 PER SHARE​.Q4 EBIT EUR 73.1‍​ MILLION (REUTERS POLL EUR 62.2 MILLION).  Full Article

Orion To Investigate Possible Sale Of Orion Diagnostica
Tuesday, 23 Jan 2018 05:20am EST 

Jan 23 (Reuters) - ORION OYJ ::REG-ORION TO INVESTIGATE POSSIBLE SALE OF ORION DIAGNOSTICA.  Full Article

Orion To Launch Negotiations That May Result In Personnel Reductions
Thursday, 4 Jan 2018 04:15am EST 

Jan 4 (Reuters) - Orion Oyj ::ORION TO RENEW OPERATING MODEL OF ITS LABORATORIES.‍COMPANY WILL LAUNCH CO-OPERATION NEGOTIATIONS IN LABORATORY OPERATIONS​.‍ORION DIAGNOSTICA'S LABORATORIES WILL NOT BE PART OF NEGOTIATIONS.​.IS TO FURTHER STREAMLINE OPERATING MODEL FOR LABORATORIES AND DEVELOP PRODUCTIVITY BY CHANGING OPERATING MODEL.​.‍NEGOTIATIONS MAY RESULT IN PERSONNEL REDUCTIONS OF A MAXIMUM OF 40 PERSONS.​.  Full Article

Peptonic Medical Enters Tech Transfer Agreement With Orion
Thursday, 21 Dec 2017 02:45am EST 

Dec 21 (Reuters) - Peptonic Medical Ab ::PEPTONIC MEDICAL AND ORION ENTER VAGIVITAL™ TECH TRANSFER AGREEMENT.‍ENTERED A TECH TRANSFER AGREEMENT WITH ORION CORPORATION, HEADQUARTERED IN ESPOO, FINLAND​.‍UNDER AGREEMENT, TWO COMPANIES WILL EXCHANGE INFORMATION AND COLLABORATE.- ‍TO PREPARE FOR COMMERCIAL MANUFACTURE OF VAGIVITAL™ - A PRODUCT THAT PEPTONIC PLANS TO LAUNCH IN 2018​.‍COMPANIES SIGNED TERMS SHEET FOR A FINAL AGREEMENT REGARDING COMMERCIAL MANUFACTURE OF VAGIVITAL™​.  Full Article

Orion Q3 EBIT EUR 56.4‍​ million, misses expectations
Thursday, 26 Oct 2017 05:00am EDT 

Oct 26 (Reuters) - ORION OYJ :‍OUTLOOK ESTIMATE FOR 2017 REMAINS UNCHANGED.​.Q3 SALES EUR ‍252.7​ MILLION (REUTERS POLL EUR 266 MILLION).‍OUTLOOK ESTIMATE FOR 2017 REMAINS UNCHANGED.​.Q3 EBIT EUR 56.4‍​ MILLION (REUTERS POLL EUR 70.5 MILLION).  Full Article

Orion Q2 EBIT EUR 71.8 mln, below estimates
Wednesday, 19 Jul 2017 06:16am EDT 

July 19 (Reuters) - ORION OYJ ::OUTLOOK ESTIMATE FOR 2017 REMAINS UNCHANGED.ESTIMATES THAT IN 2017 NET SALES WILL BE AT SIMILAR LEVEL TO 2016.Q2 NET SALES EUR ‍272.4​ MILLION (REUTERS POLL EUR 277 MILLION).SEES 2017 OPERATING PROFIT EXCLUDING MATERIAL CAPITAL GAINS WILL BE AT LEAST EUR 280 MILLION.Q2 EBIT EUR 71.8 MILLION (REUTERS POLL EUR 83.0 MILLION).SHARES DOWN 3.4 PERCENT AFTER CO PUBLISHES Q2 RESULTS.  Full Article

Orion co-operation negotiations in Oulu completed
Friday, 2 Jun 2017 04:06am EDT 

June 2 (Reuters) - ORION OYJ ::ORION DIAGNOSTICA'S CO-OPERATION NEGOTIATIONS IN OULU COMPLETED.‍NEGOTIATIONS CONCERNED 14 EMPLOYEES, WHO WILL PRIMARILY BE OFFERED A TRANSFER TO ORION DIAGNOSTICA'S LOCATION IN ESPOO.​.DECISION HAS BEEN MADE TO TERMINATE OPERATIONS OF ORION DIAGNOSTICA OY IN OULU AND MOVE OPERATIONS ENTIRELY TO ESPOO.‍OPERATIONS OF ORION DIAGNOSTICA OY IN CURRENT PREMISES WILL END BY END OF SEPTEMBER 2017 AT LATEST​.  Full Article

Orion Q1 sales up at EUR 279.2 million, above expectations
Wednesday, 26 Apr 2017 05:00am EDT 

April 26 (Reuters) - ORION OYJ : :Q1 SALES EUR 279.2 MILLION (REUTERS POLL EUR 269 MILLION).OUTLOOK ESTIMATE FOR 2017 REMAINS UNCHANGED.HIGHER OPERATING PROFIT WAS DUE TO GROWTH IN NET SALES.Q1 EBIT EUR 91.7 MILLION (REUTERS POLL EUR 80.8 MILLION).  Full Article

Orion Diagnostica initiates co-operation negotiations in Oulu
Thursday, 6 Apr 2017 07:00am EDT 

ORION OYJ : ORION DIAGNOSTICA INITIATES CO-OPERATION NEGOTIATIONS CONCERNING 14 PERSONS IN OULU . ORION DIAGNOSTICA INITIATES CO-OPERATION NEGOTIATIONS CONCERNING 14 PERSONS IN OULU . OPERATIONS OF ORION DIAGNOSTICA OY IN CURRENT PREMISES WILL END BY END OF SEPTEMBER 2017 AT LATEST. . NEGOTIATIONS CONCERN 14 EMPLOYEES. .SHOULD REDUNDANCIES OCCUR, EMPLOYER WOULD, ACCORDING TO A PRELIMINARY ESTIMATE, GIVE NOTICES DURING 2017..  Full Article

Orion Oyj Q4 EBIT at EUR 58.7 million, above estimates
Wednesday, 8 Feb 2017 05:01am EST 

Orion Oyj : Q4 sales 279.9 million euros ($298.18 million) versus 273 million euros seen in Reuters poll . Q4 EBIT 58.7 million euros (Reuters poll 56.5 million) . Proposes dividend of 1.35 euro per share and 0.20 euro special dividend per share, in total 1.55 euro per share (Reuters poll: 1.45 euro per share) . Says net sales of business division turned to growth in 2016 for first time since start of generic competition for Parkinson's franchise . CEO says "Clear growth in operating profit is explained by growth in net sales and about 22 million euros of total capital gains" .Sees 2017 net sales at similar level to 2016 and operating profit ex. material capital gains to be at least 280 million euros.  Full Article

BRIEF-Orion Q4 EBIT Above Expectations At EUR 73.1‍​ Million

* ‍ESTIMATES THAT IN 2018 NET SALES WILL BE AT SAME LEVEL OR SLIGHTLY LOWER THAN IN 2017​